Loading...

Carl Zeiss Meditec AG

AFX.DEXETRA
HealthcareMedical - Instruments & Supplies
58.20
-0.05(-0.09%)

Carl Zeiss Meditec AG (AFX.DE) Stock Overview

Explore Carl Zeiss Meditec AG’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-1.11%
1.11%
Profit Growth
1.80
38.45%
EPS Growth
1.80
38.15%
Operating Margin
12.33%
46.09%
ROE
7.57%
38.45%
Dividend Yield
0.00%
0.48%
Analyst Recommendations data is not available for AFX.DEAnalyst Recommendations details for AFX.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

CEO

Dr. Markus Weber

Employees

2,066

Headquarters

Goschwitzer Strasse 51-52, Jena

Founded

2000

Frequently Asked Questions